FIELD: endocrinology. SUBSTANCE: peptide variants of 1-34 fragment of parathyroid hormone, in which at least one residue in positions 7, 11, 23, 24. 27, 28, and 31 is cyclohehylaniline residue or at least one residue in positions 3, 16, 17, 18, 19, and 34 is alpha-aminobutyric acid, or also, alternately, at least amino acid residue in position 1 is alpha,beta-diaminopropionic acid residue and those in position 27 homoarginine residue and in position 31 norleucine residue. EFFECT: widened choice of drugs for treatment of parathyroid gland disorders. 32 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANALOGS OF PARATHYROID GLAND HORMONE | 1997 |
|
RU2198182C2 |
| GLP-1 ANALOGUES | 1999 |
|
RU2208015C2 |
| α-CYCLODEXTRIN-BASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF ANALOGS OF RELEASING-HORMONE OF LUTEINIZING HORMONE (LH-RH) | 1999 |
|
RU2214270C2 |
| SOMATOSTATIN RECEPTOR ANTAGONISTS | 1997 |
|
RU2179172C2 |
| GLP-1 ANALOGS | 1999 |
|
RU2288232C9 |
| NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
| PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES | 2015 |
|
RU2736637C2 |
| PTH-COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEIR, DNA FRAGMENT AND FUSED PROTEIN | 1993 |
|
RU2130945C1 |
| NEUROPEPTIDE-2 RECEPTOR AGONISTS | 2006 |
|
RU2430108C2 |
| ANALOGUES OF PEPTIDE LH-RF, THEIR APPLICATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1998 |
|
RU2212247C2 |
